Comparison of Antibody Responses Induced by RV144, VAX003, and VAX004 Vaccination Regimens

The RV144 prime-boost regimen demonstrated efficacy against HIV acquisition while VAX003 and VAX004 did not. Although these trials differed by risk groups, immunization regimens, and immunogens, antibody responses may have contributed to the differences observed in vaccine efficacy. We assessed HIV-...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:AIDS Res Hum Retroviruses
Autors principals: Karnasuta, Chitraporn, Akapirat, Siriwat, Madnote, Sirinan, Savadsuk, Hathairat, Puangkaew, Jiraporn, Rittiroongrad, Surawach, Rerks-Ngarm, Supachai, Nitayaphan, Sorachai, Pitisuttithum, Punnee, Kaewkungwal, Jaranit, Tartaglia, James, Sinangil, Faruk, Francis, Donald P., Robb, Merlin L., de Souza, Mark S., Michael, Nelson L., Excler, Jean-Louis, Kim, Jerome H., O'Connell, Robert J., Karasavvas, Nicos
Format: Artigo
Idioma:Inglês
Publicat: Mary Ann Liebert, Inc. 2017
Matèries:
Vaccines
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5439458/
https://ncbi.nlm.nih.gov/pubmed/28006952
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1089/aid.2016.0204
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars